This study shows that co-targeting Src with #Bosutinib blocks compensatory MCL-1 accumulation, enhancing the efficacy of MCL-1 #antagonists, inducing apoptosis in #AML cells and improving survival in preclinical models. #medsky
#STTT #OpenAccess: doi.org/10.1038/s413...
0
0
0
0